Developing a Go-To-Market Strategy for Your Lead Asset
Launching a new therapy is a complex endeavor. There are no second chances. A biotech company must be aware of the challenges, prepare meticulously, and execute across the full spectrum of critical planning activities necessary to make that launch a success. In this paper we will review the various activities, from core market access and commercial/marketing to patient outreach, manufacturing and supply chain, pharmacovigilance, regulatory, and medical affairs that are key to successful drug launches.